Verano Holdings Reports 8% Revenue Growth to $217.9 Million in Q2 2026

Verano Holdings Corp. reported its financial results for the second quarter of 2026, revealing a net revenue of $217.9 million, an increase of 8% from $202.3 million in the same period last year. The company attributed this growth to strong product momentum, particularly from its HYPHEN™ and Swift Lifts™ product lines, as well as operational improvements such as extended store hours and targeted marketing initiatives. However, gross profit decreased to $99.7 million, reflecting a gross profit margin of 46%, down from 56% in the prior year, primarily due to price compression in the wholesale segment.

The company experienced a net loss of $13.4 million for the quarter, a reduction from a net loss of $19.2 million in the same quarter of 2025. This improvement was largely driven by a lower provision for income taxes, despite an increase in operational expenses. For the first half of 2026, Verano reported a net revenue of $426.1 million, up 3% from $412.1 million in the prior year, with a net loss of $31.2 million compared to a loss of $30.7 million in the same period of 2025.

Operationally, Verano continues to expand its footprint, operating 163 retail dispensaries and 14 cultivation and processing facilities across 13 states. The company opened one new store in Florida during the quarter and has plans for further expansion. The retail segment accounted for approximately 69.5% of total revenue in the second quarter, while the wholesale segment contributed about 30.5%. The company also recorded a loss on impairment of held-for-sale assets amounting to $4.1 million during the quarter.

In terms of financial health, Verano's total current liabilities decreased to $109.4 million as of June 30, 2026, from $140.3 million at the end of 2025. The company reported cash and cash equivalents of $85.2 million, up from $82.7 million at the end of the previous year. Verano's working capital increased to $294.9 million, reflecting improved inventory management and lower income tax cash outflows. The company anticipates that its current liquidity, combined with cash generated from operations, will be sufficient to meet its short-term and long-term obligations.

Looking ahead, Verano Holdings Corp. remains focused on expanding its market presence and optimizing its operations. The company is navigating a complex regulatory environment, particularly with the recent reclassification of medical cannabis from Schedule I to Schedule III under the Controlled Substances Act, which may impact its tax liabilities and operational strategies. The company continues to evaluate its growth opportunities while managing the challenges posed by competitive pressures and market conditions.